This document summarizes a presentation by Kuxtal Biotech, a Mexican company that will provide genomic technology services. It discusses how advances in synthetic biology and genetic engineering have led to new techniques and applications. While these technologies are becoming less expensive, opportunities remain underexploited in Latin America. Kuxtal Biotech, founded by 16 biotechnology students, aims to capture the existing market and develop new opportunities in Mexico and Latin America by providing custom genes and proteins as well as specialized biotechnology solutions. The company sees a need for high quality genomic services with strong customer support in the region.

1. SUMMARY PRESENTATION
Current advances in Synthetic Biology and Genetic Engineering were achievable thanks to the
breakthroughs in the industrialization of biological sciences. By broadening the spectrum of commercially
available molecular biology reagents and equipment, new techniques have been developed yielding in
novel applications, products, and services for both laboratory and industry. As more sophisticated and
accurate technologies are developed, they also become less expensive; this leads to an expansion of the
industrial, and therefore commercial possibilities. Fresh and emerging markets provide exceptional niche
opportunities; the exponential growth of scientific development in biological sciences is currently pulling the
global market as well.
Latin America is a region with great potential regarding market development and expansion of
biotechnological products and services. From 2007 onwards, iGEM has hosted a total of 25 Mexican
teams. The rate of participation has increased 60% per year. This year there are 12 Mexican teams
registered within all iGEM categories, representing almost half of the total historic participation. The
Mexican and Latin American teams participating in the iGEM competition represent only a segment of a
niche within the synthetic gene market; in reality the market-share is much bigger. Private & public
research institutions, as well as companies and industries, develop services and products that currently, or
will eventually, require synthetic genes and optimized sequences. The need for a company that efficiently
provides such services, as well as other biotechnological solutions to industrial processes, is increasing
rapidly in Mexico and the rest of the developing World as a consequence of the biological sciences
paradigm shift.
Consolidating a Synthetic Biology enterprise that provides custom synthetically designed and
optimized genes, recombinant proteins, and specialized biotechnological solutions in the region, would
capture the existing market-share and at the same time would fuel the development of a fresh new market
that currently remains underexploited.
Integrated by sixteen undergraduate Biotechnology Engineering students with specializations in
molecular biology, bioprocesses, and business management, Kuxtal Biotech is a Mexican company that
will provide top-notch genomic technology services. Team members are: Aldo A. Díaz Jiménez, Antonio
Villarreal Larrauri, Israel Guerrero Argüero, Jorge A. VásquezPratz, Nelson G. Cano Eusebio, Rodrigo
MachadoRiveira, Mariana Nieto De León, Laura C. Amaya Hernández, Cintli C. Morales Alcalá, David I.
Maycotte Cervantes, Daniela Noriega Sierra, Roberto Rosano Lara, Yunuen Zúñiga Cruz, Alicia G. Quiroz
Rocha, Cynthia M. Avilez Bahenaand Alejandra M. RojanoNisimura. Our team advisors are MBA Cristian
S. Núñez, PhD Sonia Vázquez-Flores and M.Sc. Gerónimo Villanueva.
Kuxtal Biotech has identified the need for a company that supplies quality services with both
speed and an excelling customer support. The opportunities for business development of genomic
technologies in Mexico have been underrated. Kuxtal Biotech intends to get a grip on the already existing
market, and develop it, by supplying quality products and services with on-time deliveries, validation, and
technical assistance trough all the research and project development process. Kuxtal Biotech will be
dedicated to gene synthesis for the development and scaling of new projects related to synthetic biology,
genetic engineering, as well as other biotechnological applications within México and the Latin America.
While the market matures, Kuxtal Biotech will be positioned as the main provider of
biotechnological solutions in the region, expanding its core business from gene synthesis, to a holistic
biotechnological company that will serve as a platform to launch laboratory research into the market,
taking synthetic biology applications into the everyday life of society.
- The Kuxtal BioTech Group.